Biotechnology
2 Small Biotechs With Sagging Shares but Promising Prospects
The stocks of these two developmental concerns have slid recently, but there are reasons to believe they will improve.
Blindly Following the Consensus Is Rarely the Right Course of Action
That's why I always act incrementally when allocating new funds to the market or raising cash in my portfolio.
Stalking Entry Points in the XBI Biotech ETF
Plus an update on my SPX and Nike plays.
Mirati Therapeutics Could Soar Even Higher
Prices went vertical early this month on heavy volume.
A Six-Pack of Biotech Best Bets
Ironically, some experts now see biotech as a safe haven as the sector remains unaffected by trade wars and other global headwinds.
Amgen Charts Indicate Bounce Possible Within a Longer-Term Downtrend
In the short run the stock of this biotech giant could bounce as momentum has slowed, but the bigger picture is for further weakness.
These 3 Biotech Stocks Are Attracting Insider Buying
What are insiders buying as the market sells off in recent trading sessions?
2 Biotech Names See Directors Direct Cash to Their Shares
The stock purchases by the insiders are at companies developing treatments for breast cancer and schizophrenia.
Hopeful Signs for These 2 Small Biotech Stocks
Few parts of this biotech space are more frustrating that what I have dubbed 'Tier 3' biotech concerns.
Here's How I'm Playing an Increasingly Volatile Market With These 2 Biotechs
I am incrementally using buy-write option orders to add some shares to core holdings.